Global network of CAP accredited laboratories. Extensive test menu.
Integrated services that cover planning, management, execution and analysis.
Insight on strategies and execution for long-term value to maximise success.
Global experience in all Phases of oncology drug development.
Experience in cardiovascular trials supported by a global team of experts.
ICON has conducted diabetes trials in all global regions.
ICON and IBM are working together to revolutionise clinical trial feasibility and patient recruitment.
ICON’s risk based, patient focused methodology for the design and execution of an adaptive monitoring strategies.
Using data to design, simulate, and analyse adaptive clinical trials with ease.
Watch commentary, ideas and insights on key issues affecting drug development and digital disruption in healthcare.
Insights from ICON professionals on current drug development issues.
Thought leadership, white papers and media articles from ICON.
ICON experts and guest speakers present on topical issues.
From a small team of 5 people in 1990, ICON now employs over 11,700 professionals in 38 countries.
We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.
ICON has a global network of resources to support clinical development programs.
The Board sets ICON’s strategy and oversees its implementation by Executive Management.
We currently have no upcoming recruitment events. Check back again soon for updates.
To learn more about the latest ICON career opportunities, visit the Careers section of our website.